SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001213900-20-039689
Filing Date
2020-11-27
Accepted
2020-11-27 17:00:36
Documents
3
Group Members
EDWARD TERINOJAMES C. ROUMELLMATTHEW M. LOAR

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ea130634-sc13droumell_enzo.htm SC 13D 151772
2 JOINT FILING AND SOLICITATION AGREEMENT BY AND AMONG THE REPORTING PERSONS, DATE ea130634ex99-1_enzobiochem.htm EX-99.1 15869
3 FORM OF INDEMNIFICATION LETTER AGREEMENT ea130634ex99-2_enzobiochem.htm EX-99.2 19482
  Complete submission text file 0001213900-20-039689.txt   188714
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Subject) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: SC 13D | Act: 34 | File No.: 005-32878 | Film No.: 201355752
SIC: 8071 Services-Medical Laboratories

Mailing Address 2 WISCONSIN CIR SUITE 640 CHEVY CHASE MD 20815
Business Address 2 WISCONSIN CIR SUITE 640 CHEVY CHASE MD 20815 301-656-8500
Roumell Asset Management, LLC (Filed by) CIK: 0001331693 (see all company filings)

IRS No.: 522145132 | State of Incorp.: MD | Fiscal Year End: 1231
Type: SC 13D